JO
YARW

John Overdeck’s Yarrow Bioscience YARW Stock Holding History

John Overdeck’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286K Buy
8,776
+248
+3% +$8.04K ﹤0.01% 4557
2026
Q1 		$255K Buy
8,528
+4,128
+94% +$120K ﹤0.01% 4167
2025
Q4 		$128K Sell
4,400
-16
-0.4% -$321 ﹤0.01% 3835
2025
Q3 		$74K Buy
+4,416
New +$144K ﹤0.01% 3507
2021
Q4 		– Sell
-90
Closed -$113K – 4941
2021
Q3 		$113K Buy
90
+38
+73% +$73.7K ﹤0.01% 4071
2021
Q2 		$165K Sell
52
-279
-84% -$1.1M ﹤0.01% 3831
2021
Q1 		$2.04M Buy
331
+74
+29% +$537K 0.01% 1694
2020
Q4 		$1.46M Buy
257
+167
+186% +$1.05M ﹤0.01% 1717
2020
Q3 		$540K Sell
90
-50
-36% -$292K ﹤0.01% 2187
2020
Q2 		$873K Buy
+140
New +$948K ﹤0.01% 1624
2019
Q3 		– Sell
-7
Closed -$156K – 3834
2019
Q2 		$156K Buy
7
+4
+133% +$99K ﹤0.01% 3135
2019
Q1 		$85K Sell
3
-9
-75% -$216K ﹤0.01% 2912
2018
Q4 		$172K Sell
12
-19
-61% -$425K ﹤0.01% 2743
2018
Q3 		$1.1M Buy
+31
New +$957K ﹤0.01% 1905

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

John Overdeck's YARW Position: Q2 2026 in Review

John Overdeck increased its Yarrow Bioscience (YARW) stake by 2.9% in Q2 2026, buying an estimated $8.04K and bringing the position to 8,776 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #4557.

John Overdeck first reported a position in YARW in Q3 2018 and has held it in 14 quarters since. The position peaked at $2.04M in Q1 2021. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • John Overdeck held 8,776 shares of Yarrow Bioscience worth $286K as of Q2 2026.
  • John Overdeck bought 248 Yarrow Bioscience shares in Q2 2026, an estimated $8.04K.
  • Yarrow Bioscience made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4557 holding.
  • John Overdeck first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 14 quarters since.
  • John Overdeck's Yarrow Bioscience position peaked at $2.04M in Q1 2021.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.